Literature DB >> 23746549

Mutations in KLHL40 are a frequent cause of severe autosomal-recessive nemaline myopathy.

Gianina Ravenscroft1, Satoko Miyatake, Vilma-Lotta Lehtokari, Emily J Todd, Pauliina Vornanen, Kyle S Yau, Yukiko K Hayashi, Noriko Miyake, Yoshinori Tsurusaki, Hiroshi Doi, Hirotomo Saitsu, Hitoshi Osaka, Sumimasa Yamashita, Takashi Ohya, Yuko Sakamoto, Eriko Koshimizu, Shintaro Imamura, Michiaki Yamashita, Kazuhiro Ogata, Masaaki Shiina, Robert J Bryson-Richardson, Raquel Vaz, Ozge Ceyhan, Catherine A Brownstein, Lindsay C Swanson, Sophie Monnot, Norma B Romero, Helge Amthor, Nina Kresoje, Padma Sivadorai, Cathy Kiraly-Borri, Goknur Haliloglu, Beril Talim, Diclehan Orhan, Gulsev Kale, Adrian K Charles, Victoria A Fabian, Mark R Davis, Martin Lammens, Caroline A Sewry, Adnan Manzur, Francesco Muntoni, Nigel F Clarke, Kathryn N North, Enrico Bertini, Yoram Nevo, Ekkhard Willichowski, Inger E Silberg, Haluk Topaloglu, Alan H Beggs, Richard J N Allcock, Ichizo Nishino, Carina Wallgren-Pettersson, Naomichi Matsumoto, Nigel G Laing.   

Abstract

Nemaline myopathy (NEM) is a common congenital myopathy. At the very severe end of the NEM clinical spectrum are genetically unresolved cases of autosomal-recessive fetal akinesia sequence. We studied a multinational cohort of 143 severe-NEM-affected families lacking genetic diagnosis. We performed whole-exome sequencing of six families and targeted gene sequencing of additional families. We identified 19 mutations in KLHL40 (kelch-like family member 40) in 28 apparently unrelated NEM kindreds of various ethnicities. Accounting for up to 28% of the tested individuals in the Japanese cohort, KLHL40 mutations were found to be the most common cause of this severe form of NEM. Clinical features of affected individuals were severe and distinctive and included fetal akinesia or hypokinesia and contractures, fractures, respiratory failure, and swallowing difficulties at birth. Molecular modeling suggested that the missense substitutions would destabilize the protein. Protein studies showed that KLHL40 is a striated-muscle-specific protein that is absent in KLHL40-associated NEM skeletal muscle. In zebrafish, klhl40a and klhl40b expression is largely confined to the myotome and skeletal muscle, and knockdown of these isoforms results in disruption of muscle structure and loss of movement. We identified KLHL40 mutations as a frequent cause of severe autosomal-recessive NEM and showed that it plays a key role in muscle development and function. Screening of KLHL40 should be a priority in individuals who are affected by autosomal-recessive NEM and who present with prenatal symptoms and/or contractures and in all Japanese individuals with severe NEM.
Copyright © 2013 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23746549      PMCID: PMC3710748          DOI: 10.1016/j.ajhg.2013.05.004

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  36 in total

1.  Merlin--rapid analysis of dense genetic maps using sparse gene flow trees.

Authors:  Gonçalo R Abecasis; Stacey S Cherny; William O Cookson; Lon R Cardon
Journal:  Nat Genet       Date:  2001-12-03       Impact factor: 38.330

2.  Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations.

Authors:  Raphael Guerois; Jens Erik Nielsen; Luis Serrano
Journal:  J Mol Biol       Date:  2002-07-05       Impact factor: 5.469

3.  Migration of zebrafish spinal motor nerves into the periphery requires multiple myotome-derived cues.

Authors:  Jörg Zeller; Valerie Schneider; Saniniuj Malayaman; Shin-ichi Higashijima; Hitoshi Okamoto; Jianfang Gui; Shuo Lin; Michael Granato
Journal:  Dev Biol       Date:  2002-12-15       Impact factor: 3.582

4.  Infant with high arched palate, bell-shaped chest, joint contractures, and intrauterine fractures.

Authors:  Atilano G Lacson; Gail Donaldson; Enid Gilbert Barness; Judith D Ranells; Herbert H Pomerance
Journal:  Pediatr Pathol Mol Med       Date:  2002 Nov-Dec

5.  The age of a neutral mutant persisting in a finite population.

Authors:  M Kimura; T Ohta
Journal:  Genetics       Date:  1973-09       Impact factor: 4.562

6.  A novel nemaline myopathy in the Amish caused by a mutation in troponin T1.

Authors:  J J Johnston; R I Kelley; T O Crawford; D H Morton; R Agarwala; T Koch; A A Schäffer; C A Francomano; L G Biesecker
Journal:  Am J Hum Genet       Date:  2000-08-21       Impact factor: 11.025

7.  Lethal arthrogryposis multiplex congenita: a pathological study of 21 cases.

Authors:  C M Quinn; J S Wigglesworth; J Heckmatt
Journal:  Histopathology       Date:  1991-08       Impact factor: 5.087

8.  Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases.

Authors:  Manabu Furukawa; Yizhou Joseph He; Christoph Borchers; Yue Xiong
Journal:  Nat Cell Biol       Date:  2003-10-05       Impact factor: 28.824

9.  Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases.

Authors:  Peter Canning; Christopher D O Cooper; Tobias Krojer; James W Murray; Ashley C W Pike; Apirat Chaikuad; Tracy Keates; Chancievan Thangaratnarajah; Viktorija Hojzan; Vikram Ayinampudi; Brian D Marsden; Opher Gileadi; Stefan Knapp; Frank von Delft; Alex N Bullock
Journal:  J Biol Chem       Date:  2013-01-24       Impact factor: 5.157

10.  Molecular phylogeny of the kelch-repeat superfamily reveals an expansion of BTB/kelch proteins in animals.

Authors:  Soren Prag; Josephine C Adams
Journal:  BMC Bioinformatics       Date:  2003-09-17       Impact factor: 3.169

View more
  80 in total

1.  Cullin-3-RING ubiquitin ligase activity is required for striated muscle function in mice.

Authors:  James B Papizan; Alexander H Vidal; Svetlana Bezprozvannaya; Rhonda Bassel-Duby; Eric N Olson
Journal:  J Biol Chem       Date:  2018-04-13       Impact factor: 5.157

2.  New Mutations in NEB Gene Discovered by Targeted Next-Generation Sequencing in Nemaline Myopathy Italian Patients.

Authors:  Daniela Piga; Francesca Magri; Dario Ronchi; Stefania Corti; Denise Cassandrini; Eugenio Mercuri; Giorgio Tasca; Enrico Bertini; Fabiana Fattori; Antonio Toscano; Sonia Messina; Isabella Moroni; Marina Mora; Maurizio Moggio; Irene Colombo; Teresa Giugliano; Marika Pane; Chiara Fiorillo; Adele D'Amico; Claudio Bruno; Vincenzo Nigro; Nereo Bresolin; Giacomo Pietro Comi
Journal:  J Mol Neurosci       Date:  2016-04-22       Impact factor: 3.444

3.  Treatment with ActRIIB-mFc Produces Myofiber Growth and Improves Lifespan in the Acta1 H40Y Murine Model of Nemaline Myopathy.

Authors:  Jennifer Tinklenberg; Hui Meng; Lin Yang; Fujun Liu; Raymond G Hoffmann; Mahua Dasgupta; Kenneth P Allen; Alan H Beggs; Edna C Hardeman; R Scott Pearsall; Robert H Fitts; Michael W Lawlor
Journal:  Am J Pathol       Date:  2016-04-18       Impact factor: 4.307

4.  Clinical utility gene card for: Nemaline myopathy - update 2015.

Authors:  Kristen J Nowak; Mark R Davis; Carina Wallgren-Pettersson; Phillipa J Lamont; Nigel G Laing
Journal:  Eur J Hum Genet       Date:  2015-02-25       Impact factor: 4.246

5.  Leiomodin-3 dysfunction results in thin filament disorganization and nemaline myopathy.

Authors:  Michaela Yuen; Sarah A Sandaradura; James J Dowling; Alla S Kostyukova; Natalia Moroz; Kate G Quinlan; Vilma-Lotta Lehtokari; Gianina Ravenscroft; Emily J Todd; Ozge Ceyhan-Birsoy; David S Gokhin; Jérome Maluenda; Monkol Lek; Flora Nolent; Christopher T Pappas; Stefanie M Novak; Adele D'Amico; Edoardo Malfatti; Brett P Thomas; Stacey B Gabriel; Namrata Gupta; Mark J Daly; Biljana Ilkovski; Peter J Houweling; Ann E Davidson; Lindsay C Swanson; Catherine A Brownstein; Vandana A Gupta; Livija Medne; Patrick Shannon; Nicole Martin; David P Bick; Anders Flisberg; Eva Holmberg; Peter Van den Bergh; Pablo Lapunzina; Leigh B Waddell; Darcée D Sloboda; Enrico Bertini; David Chitayat; William R Telfer; Annie Laquerrière; Carol C Gregorio; Coen A C Ottenheijm; Carsten G Bönnemann; Katarina Pelin; Alan H Beggs; Yukiko K Hayashi; Norma B Romero; Nigel G Laing; Ichizo Nishino; Carina Wallgren-Pettersson; Judith Melki; Velia M Fowler; Daniel G MacArthur; Kathryn N North; Nigel F Clarke
Journal:  J Clin Invest       Date:  2014-09-24       Impact factor: 14.808

6.  Mutations in Subunits of the Activating Signal Cointegrator 1 Complex Are Associated with Prenatal Spinal Muscular Atrophy and Congenital Bone Fractures.

Authors:  Ellen Knierim; Hiromi Hirata; Nicole I Wolf; Susanne Morales-Gonzalez; Gudrun Schottmann; Yu Tanaka; Sabine Rudnik-Schöneborn; Mickael Orgeur; Klaus Zerres; Stefanie Vogt; Anne van Riesen; Esther Gill; Franziska Seifert; Angelika Zwirner; Janbernd Kirschner; Hans Hilmar Goebel; Christoph Hübner; Sigmar Stricker; David Meierhofer; Werner Stenzel; Markus Schuelke
Journal:  Am J Hum Genet       Date:  2016-02-25       Impact factor: 11.025

7.  Expanding the phenotype associated with the NEFL mutation: neuromuscular disease in a family with overlapping myopathic and neurogenic findings.

Authors:  Pankaj B Agrawal; Mugdha Joshi; Nicholas S Marinakis; Klaus Schmitz-Abe; Pedro D S C Ciarlini; Jane C Sargent; Kyriacos Markianos; Umberto De Girolami; David A Chad; Alan H Beggs
Journal:  JAMA Neurol       Date:  2014-11       Impact factor: 18.302

8.  Myostatin inhibition using mRK35 produces skeletal muscle growth and tubular aggregate formation in wild type and TgACTA1D286G nemaline myopathy mice.

Authors:  Jennifer A Tinklenberg; Emily M Siebers; Margaret J Beatka; Hui Meng; Lin Yang; Zizhao Zhang; Jacob A Ross; Julien Ochala; Carl Morris; Jane M Owens; Nigel G Laing; Kristen J Nowak; Michael W Lawlor
Journal:  Hum Mol Genet       Date:  2018-02-15       Impact factor: 6.150

9.  The progression of the ClinGen gene clinical validity classification over time.

Authors:  Jennifer L McGlaughon; Jennifer L Goldstein; Courtney Thaxton; Sarah E Hemphill; Jonathan S Berg
Journal:  Hum Mutat       Date:  2018-11       Impact factor: 4.878

10.  KLHL40 deficiency destabilizes thin filament proteins and promotes nemaline myopathy.

Authors:  Ankit Garg; Jason O'Rourke; Chengzu Long; Jonathan Doering; Gianina Ravenscroft; Svetlana Bezprozvannaya; Benjamin R Nelson; Nadine Beetz; Lin Li; She Chen; Nigel G Laing; Robert W Grange; Rhonda Bassel-Duby; Eric N Olson
Journal:  J Clin Invest       Date:  2014-06-24       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.